Amarin Corp Plcuk (AMRN) Revenue (2013 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Revenue of $45.1 million for Q1 2026, up 7.41% YoY from $42.0 million in Q1 2025, and down 8.3% sequentially from $49.2 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Revenue (2013 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Revenue across 14 years of filings, most recently posting $45.1 million for Q1 2026.
- In Q1 2026, Revenue rose 7.41% year-over-year to $45.1 million; the TTM figure through Mar 2026 stood at $216.8 million (up 1.24% YoY), while the FY2025 annual figure was $213.6 million, down 6.55% from the prior year.
- Revenue retreated to $45.1 million in Q1 2026, from $49.2 million in the prior quarter.
- Over the last five years, Revenue for AMRN reached as high as $94.6 million in Q1 2022 and fell as low as $42.0 million in Q1 2025.
- The 5-year median for Revenue is $67.5 million (2024), against an average of $68.4 million.
- Annual changes were most pronounced in 2022 — Revenue plunged 38.87% — and 2025, when it climbed 17.43%.
- A 5-year view of Revenue shows it stood at $90.2 million in 2022, then dropped by 17.21% to $74.7 million in 2023, then decreased by 16.61% to $62.3 million in 2024, then declined by 21.0% to $49.2 million in 2025, then fell by 8.3% to $45.1 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $45.1 million, $49.2 million, and $49.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 19.80 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 24.06 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 15.00 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 14.39 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 16.29 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 8.62 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 6.96 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.34 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | 45.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.13 Mn |
| Dec 31, 2025 | 49.22 Mn |
| Sep 30, 2025 | 49.67 Mn |
| Jun 30, 2025 | 72.74 Mn |
| Mar 31, 2025 | 42.02 Mn |
| Dec 31, 2024 | 62.31 Mn |
| Sep 30, 2024 | 42.30 Mn |
| Jun 30, 2024 | 67.49 Mn |
| Mar 31, 2024 | 56.52 Mn |
| Dec 31, 2023 | 74.71 Mn |
| Sep 30, 2023 | 66.06 Mn |
| Jun 30, 2023 | 80.17 Mn |
| Mar 31, 2023 | 85.98 Mn |
| Dec 31, 2022 | 90.25 Mn |
| Sep 30, 2022 | 89.88 Mn |
| Jun 30, 2022 | 94.44 Mn |
| Mar 31, 2022 | 94.63 Mn |
| Dec 31, 2021 | 144.49 Mn |
| Sep 30, 2021 | 142.04 Mn |
| Jun 30, 2021 | 154.49 Mn |